EP 1992635 A1 20081119 - Immunostimulatory sequence oligonucleotides and methods of using the same
Title (en)
Immunostimulatory sequence oligonucleotides and methods of using the same
Title (de)
Immunstimulierende Sequenz-Oligonukleotide und Verwendungsverfahren dafür
Title (fr)
Oligonucléotides à séquence immunostimulatrice et ses procédés d'utilisation
Publication
Application
Priority
- EP 03814325 A 20031218
- US 43612202 P 20021223
- US 44788503 P 20030213
- US 46754603 P 20030501
Abstract (en)
The invention provides immunomodulatory polynucleotides and methods for immunomodulation of individuals using the immunomodulatory polynucleotides.
IPC 8 full level
C07H 21/00 (2006.01); C07H 21/02 (2006.01); C07H 21/04 (2006.01); C12N 15/117 (2010.01)
CPC (source: EP KR US)
A01N 43/04 (2013.01 - KR); A61P 11/02 (2018.01 - EP); A61P 11/06 (2018.01 - EP); A61P 17/00 (2018.01 - EP); A61P 17/04 (2018.01 - EP); A61P 27/02 (2018.01 - EP); A61P 31/00 (2018.01 - EP); A61P 33/00 (2018.01 - EP); A61P 37/02 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61P 37/08 (2018.01 - EP); A61P 39/02 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07H 21/00 (2013.01 - EP US); C07H 21/02 (2013.01 - EP KR US); C07H 21/04 (2013.01 - EP KR US); C12N 15/117 (2013.01 - EP US); C12N 2310/17 (2013.01 - EP US); C12N 2310/315 (2013.01 - EP US); C12N 2310/333 (2013.01 - EP US); C12N 2310/336 (2013.01 - EP US); Y02A 50/30 (2018.01 - EP)
Citation (applicant)
- WO 9855495 A2 19981210 - DYNAVAX TECH CORP [US], et al
- EP 0468520 A2 19920129 - MITSUI TOATSU CHEMICALS [JP]
- WO 9602555 A1 19960201 - UNIV IOWA RES FOUND [US]
- WO 9728259 A1 19970807 - UNIV CALIFORNIA [US]
- WO 9816247 A1 19980423 - UNIV CALIFORNIA [US], et al
- WO 9818810 A1 19980507 - UNIV IOWA RES FOUND [US], et al
- WO 9837919 A1 19980903 - UNIV IOWA RES FOUND [US]
- WO 9840100 A1 19980917 - OTTAWA CIVIC LOEB RES INST [CA], et al
- WO 9852581 A1 19981126 - OTTAWA CIVIC HOSPITAL LOEB RES [CA], et al
- WO 9855609 A1 19981210 - UNIV CALIFORNIA [US]
- WO 9911275 A2 19990311 - UNIV CALIFORNIA [US]
- WO 9852962 A1 19981126 - MERCK & CO INC [US], et al
- WO 9933488 A2 19990708 - SMITHKLINE BEECHAM BIOLOG [BE], et al
- WO 9933868 A2 19990708 - SMITHKLINE BEECHAM BIOLOG [BE], et al
- WO 9951259 A2 19991014 - UNIV IOWA RES FOUND [US]
- WO 9962923 A2 19991209 - DYNAVAX TECH CORP [US], et al
- US 5663153 A 19970902 - HUTCHERSON STEPHEN L [US], et al
- US 5723335 A 19980303 - HUTCHERSON STEPHEN L [US], et al
- US 5849719 A 19981215 - CARSON DENNIS A [US], et al
- WO 9956755 A1 19991111 - UNIV IOWA RES FOUND [US], et al
- WO 9961056 A2 19991202 - LOEB HEALTH RESEARCH INST AT T [CA], et al
- WO 0006588 A1 20000210 - UNIV IOWA RES FOUND [US], et al
- WO 0016804 A1 20000330 - DYNAVAX TECH CORP [US], et al
- WO 0021556 A1 20000420 - DYNAVAX TECH CORP [US], et al
- WO 0054803 A2 20000921 - PANACEA PHARM LLC [US]
- WO 0061151 A2 20001019 - US HEALTH [US], et al
- WO 0067023 A1 20001109 - CPG IMMUNOPHARMACEUTICALS GMBH [DE], et al
- WO 0067787 A2 20001116 - IMMUNE RESPONSE CORP INC [US], et al
- US 6090791 A 20000718 - SATO YUKIO [JP], et al
- WO 0115726 A2 20010308 - INEX PHARMACEUTICALS CORP [CA], et al
- WO 0112223 A2 20010222 - DYNAVAX TECH CORP [US], et al
- WO 0122972 A2 20010405 - UNIV IOWA RES FOUND [US], et al
- WO 0122990 A2 20010405 - COLEY PHARM GROUP INC [US], et al
- WO 0135991 A2 20010525 - DYNAVAX TECH CORP [US], et al
- WO 0151500 A1 20010719 - US HEALTH [US], et al
- WO 0154720 A1 20010802 - CISTEM BIOTECHNOLOGIES GMBH [AT], et al
- US 6174872 B1 20010116 - CARSON DENNIS A [US], et al
- US 6194388 B1 20010227 - KRIEG ARTHUR M [US], et al
- US 6207646 B1 20010327 - KRIEG ARTHUR M [US], et al
- US 6214806 B1 20010410 - KRIEG ARTHUR M [US], et al
- US 6218371 B1 20010417 - KRIEG ARTHUR M [US], et al
- US 6239116 B1 20010529 - KRIEG ARTHUR M [US], et al
- WO 0112804 A2 20010222 - HYBRIDON INC [US]
- WO 0145750 A1 20010628 - UNIV CALIFORNIA [US], et al
- WO 0155341 A2 20010802 - UNIV CALIFORNIA [US], et al
- WO 0155370 A2 20010802 - HYBRIDON INC [US]
- WO 0162207 A2 20010830 - UNIV CALIFORNIA [US], et al
- WO 0168077 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0168078 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0168103 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0168116 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0168117 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0168143 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0168144 A2 20010920 - DYNAVAX TECH CORP [US], et al
- WO 0172123 A1 20011004 - UNIV CALIFORNIA [US], et al
- WO 0176642 A1 20011018 - UNIV CALIFORNIA [US], et al
- WO 0183503 A2 20011108 - HYBRIDON INC [US]
- WO 0193902 A2 20011213 - BIOSYNEXUS INC [US]
- WO 0226757 A2 20020404 - HYBRIDON INC [US]
- WO 02052002 A2 20020704 - DYNAVAX TECH CORP [US], et al
- WO 02069369 A2 20020906 - COLEY PHARMACEUTICAL GROUP LTD, et al
- WO 02074922 A2 20020926 - UNIV CALIFORNIA [US], et al
- US 6339068 B1 20020115 - KRIEG ARTHUR M [US], et al
- US 6406705 B1 20020618 - DAVIS HEATHER L [CA], et al
- US 6426334 B1 20020730 - AGRAWAL SUDHIR [US], et al
- US 6426336 B1 20020730 - CARSON DENNIS A [US], et al
- US 6429199 B1 20020806 - KRIEG ARTHUR M [US], et al
- US 6476000 B1 20021105 - AGRAWAL SUDHIR [US]
- US 5124246 A 19920623 - URDEA MICHAEL S [US], et al
- US 4650675 A 19870317 - BOREL YVES [US], et al
- US 4458066 A 19840703 - CARUTHERS MARVIN H [US], et al
- US 5453496 A 19950926 - CARUTHERS MARVIN H [US], et al
- US 4910300 A 19900320 - URDEA MICHAEL S [US], et al
- US 4948882 A 19900814 - RUTH JERRY L [US]
- US 5093232 A 19920303 - URDEA MICHAEL S [US], et al
- US 4849513 A 19890718 - SMITH LLOYD M [CA], et al
- US 5015733 A 19910514 - SMITH LLOYD M [US], et al
- US 5118800 A 19920602 - SMITH LLOYD M [US], et al
- US 5118802 A 19920602 - SMITH LLOYD M [US], et al
- US 5391723 A 19950221 - PRIEST JOHN H [US]
- US 5552391 A 19960903 - COUTTS STEPHEN M [US], et al
- US 5460831 A 19951024 - KOSSOVSKY NIR [US], et al
- US 40296802 P 20020812
- US 5484596 A 19960116 - HANNA JR MICHAEL G [US], et al
- MANZEL ET AL., ANTISENSE NUCL. ACID DRUG DEV., vol. 9, 1999, pages 459 - 464
- VERTHELYI ET AL., J IMMUNOL., vol. 166, 2001, pages 2372 - 2377
Citation (search report)
- [YD] WO 02052002 A2 20020704 - DYNAVAX TECH CORP [US], et al
- [PY] ROTHENFUSSER S ET AL: "RECENT ADVANCES IN IMMUNOSTIMULATORY CPG OLIGONUCLEOTIDES", CURRENT OPINION IN MOLECULAR THERAPEUTICS, CURRENT DRUGS, LONDON, GB, vol. 5, no. 2, 1 April 2003 (2003-04-01), pages 98 - 106, XP009037365, ISSN: 1464-8431
- [PY] MARSHALL JASON D ET AL: "Identification of a novel CpG DNA class and motif that optimally stimulate B cell and plasmacytoid dendritic cell functions.", JOURNAL OF LEUKOCYTE BIOLOGY JUN 2003, vol. 73, no. 6, June 2003 (2003-06-01), pages 781 - 792, XP002497698, ISSN: 0741-5400
- [PY] HARTMANN G ET AL: "RATIONAL DESIGN OF NEW CPG OLIGONUCLEOTIDES THAT COMBINE B CELL ACTIVATION WITH HIGH IFN-ALPHA INDUCTION IN PLASMACYTOID DENDRITIC CELLS", EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY - V C H VERLAG GMBH & CO. KGAA, DE, vol. 33, no. 6, 1 June 2003 (2003-06-01), pages 1633 - 1641, XP009015493, ISSN: 0014-2980
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004058179 A2 20040715; WO 2004058179 A3 20041111; AT E442376 T1 20090915; AT E544772 T1 20120215; AU 2003297483 A1 20040722; AU 2003297483 B2 20101118; CA 2511475 A1 20040715; CA 2511475 C 20131119; CN 100546998 C 20091007; CN 101693890 A 20100414; CN 101693890 B 20120905; CN 1745089 A 20060308; CY 1109642 T1 20140813; CY 1112704 T1 20160210; DE 60329223 D1 20091022; DK 1575977 T3 20091109; DK 1992635 T3 20120305; EP 1575977 A2 20050921; EP 1575977 A4 20060426; EP 1575977 B1 20090909; EP 1992635 A1 20081119; EP 1992635 B1 20120208; ES 2328807 T3 20091118; ES 2381309 T3 20120525; HK 1125943 A1 20090821; JP 2006512096 A 20060413; JP 2012070757 A 20120412; JP 5102959 B2 20121219; KR 101178816 B1 20120907; KR 101309501 B1 20130924; KR 20050089983 A 20050909; KR 20120046326 A 20120509; KR 20120128729 A 20121127; NZ 541027 A 20080430; PT 1575977 E 20091215; PT 1992635 E 20120320; SG 173219 A1 20110829; SG 2011035342 A 20161229; SI 1575977 T1 20100129; US 2006058254 A1 20060316; US 7745606 B2 20100629
DOCDB simple family (application)
US 0341001 W 20031218; AT 03814325 T 20031218; AT 08013086 T 20031218; AU 2003297483 A 20031218; CA 2511475 A 20031218; CN 200380107301 A 20031218; CN 200910170406 A 20031218; CY 091101221 T 20091125; CY 121100394 T 20120425; DE 60329223 T 20031218; DK 03814325 T 20031218; DK 08013086 T 20031218; EP 03814325 A 20031218; EP 08013086 A 20031218; ES 03814325 T 20031218; ES 08013086 T 20031218; HK 09104499 A 20090518; JP 2005510051 A 20031218; JP 2011276052 A 20111216; KR 20057011912 A 20031218; KR 20127008544 A 20031218; KR 20127025824 A 20031218; NZ 54102703 A 20031218; PT 03814325 T 20031218; PT 08013086 T 20031218; SG 2007045727 A 20031218; SG 2011035342 A 20031218; SI 200331695 T 20031218; US 74172003 A 20031218